11 results

• Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators

  July 15, 2025

  Irvin Jackson

  U.K. health regulators are urging users of drugs like Ozempic and Mounjaro to report cases of acute pancreatitis as part of an ongoing genetic investigation.

• Saxenda, Wegovy Vision Loss Lawsuit Filed Over NAION Diagnosis

  June 13, 2025

  Irvin Jackson

  A Wegovy and Saxenda lawsuit claims that the two weight loss drugs caused a rare eye condition that led to blurred vision as well as vision loss in a woman’s right eye.

• Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL

  November 15, 2024

  Irvin Jackson

  Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

• European Regulators Seek More Data on Ozempic Suicide Risks

  December 5, 2023

  Irvin Jackson

  Concerns over potential Ozempic suicide risks have led European regulators to expand its investigation to the entire class of diabetes and weight loss drugs.

• Ozempic Suicide Risks Result in Investigation by European Medicines Agency

  July 11, 2023

  Irvin Jackson

  European regulators have launched an investigation into Ozempic suicide risks following reports of users experiencing desires to harm themselves in Iceland.

• Trulicity, Byetta, Victoza, Similar Diabetes Drugs Do Not Appear to Increase Breast Cancer Risks: Study

  March 25, 2021

  Martha Garcia

  A new study finds no link between popular diabetes drugs like Byetta and Trulicity, and an increased risk of breast cancer.

• Following Belviq Recall, Study Analyzes Benefits, Risks of Various Weight Loss Drugs

  March 24, 2020

  Irvin Jackson

  A new review looks at a variety of weight loss drugs following the Belviq recall, saying most are safe, but must be used wisely and not as a cure-all for obesity.

• Victoza May Be Linked to Gallbladder Problems, Researchers Warn

  November 10, 2015

  Irvin Jackson

  Researchers who recently found that the active ingredient in Victoza and Saxenda could cause weight loss are now warning that their study also appeared to show signs of an association with gallbladder problems.

• Study Backs Claims That Victoza Side Effects Cause Weight Loss in Diabetics

  August 19, 2015

  Irvin Jackson

  A new study shows significant weight loss through Victoza use but warns of increased risk of gastrointestinal disorders.

• Side Effects of Saxenda, Victoza May Increase Colon Cancer Risks: Study

  March 10, 2015

  Irvin Jackson

  Canadian researchers say tests on mice suggest that certain weight loss and diabetes drugs may increase the risk of colon cancer, particularly for patients who have undergone bariatric surgery.